Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;19(1):28-34.
doi: 10.1038/pcan.2015.63. Epub 2016 Jan 12.

Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population

L A Henríquez-Hernández  1   2   3 , A Valenciano  2 , P Foro-Arnalot  4 , M J Álvarez-Cubero  5   6 , J M Cozar  7 , J F Suárez-Novo  8 , M Castells-Esteve  8 , P Fernández-Gonzalo  9 , B De-Paula-Carranza  9 , M Ferrer  10 , F Guedea  11 , G Sancho-Pardo  12 , J Craven-Bartle  12 , M J Ortiz-Gordillo  13 , P Cabrera-Roldán  13 , J I Rodríguez-Melcón  1   2 , E Herrera-Ramos  14   15 , C Rodríguez-Gallego  14 , P C Lara  1   2   3
Affiliations
Free article

Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population

L A Henríquez-Hernández et al. Prostate Cancer Prostatic Dis. 2016 Mar.
Free article

Abstract

Background: Novel predictors of prognosis and treatment response for prostate cancer (PCa) are required to better individualize treatment. Single-nucleotide polymorphisms (SNPs) in four genes directly (XRCC5 (X-ray repair complementing defective repair in Chinese hamster cells 5) and XRCC6 (X-ray repair complementing defective repair in Chinese hamster cells 6)) or indirectly (PARP1 and major vault protein (MVP)) involved in non-homologous end joining were examined in 494 Spanish PCa patients.

Methods: A total of 22 SNPs were genotyped in a Biotrove OpenArray NT Cycler. Clinical tumor stage, diagnostic PSA serum levels and Gleason score at diagnosis were obtained for all participants. Genotypic and allelic frequencies were determined using the web-based environment SNPator.

Results: (XRCC6) rs2267437 appeared as a risk factor for developing more aggressive PCa tumors. Those patients carrying the GG genotype were at higher risk of developing bigger tumors (odds ratio (OR)=2.04, 95% confidence interval (CI) 1.26-3.29, P=0.004), present higher diagnostic PSA levels (OR=2.12, 95% CI 1.19-3.78, P=0.011), higher Gleason score (OR=1.65, 95% CI 1.01-2.68, P=0.044) and D'Amico higher risk tumors (OR=2.38, 95% CI 1.24-4.58, P=0.009) than those patients carrying the CC/CG genotypes. Those patients carrying the (MVP) rs3815824 TT genotype were at higher risk of presenting higher diagnostic PSA levels (OR=4.74, 95% CI 1.40-16.07, P=0.013) than those patients carrying the CC genotype. When both SNPs were analyzed in combination, those patients carrying the risk genotypes were at higher risk of developing D'Amico higher risk tumors (OR=3.33, 95% CI 1.56-7.17, P=0.002).

Conclusions: We believe that for the first time, genetic variants at XRCC6 and MVP genes are associated with risk of more aggressive disease, and would be taken into account when assessing the malignancy of PCa.

PubMed Disclaimer

References

    1. Leuk Res. 2011 Sep;35(9):1178-83 - PubMed
    1. Asian J Androl. 2014 May-Jun;16(3):401-6 - PubMed
    1. Mol Aspects Med. 2013 Dec;34(6):1124-37 - PubMed
    1. Nucleic Acids Res. 2003 Sep 1;31(17):4959-64 - PubMed
    1. DNA Repair (Amst). 2004 Aug-Sep;3(8-9):781-96 - PubMed

Publication types

MeSH terms